Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk

NCT02313584 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

464

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Thromboembolism

Interventions

DRUG: dabigatran
DRUG: placebo

Sponsor

Korea University